A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...